To provide for a limitation on availability of funds for Executive Office of the President, Office of National Drug Control Policy, Salaries and Expenses for fiscal year 2024.

Bill 118 hr 2071, also known as the "Limitation on Availability of Funds for Executive Office of the President, Office of National Drug Control Policy, Salaries and Expenses for Fiscal Year 2024," aims to restrict the amount of funds that can be allocated to the Office of National Drug Control Policy within the Executive Office of the President for the fiscal year 2024.

The bill sets a specific limit on the amount of money that can be used for salaries and expenses within this office, in an effort to control spending and ensure that taxpayer dollars are being used efficiently and effectively. This limitation is intended to promote accountability and transparency within the Office of National Drug Control Policy, as well as to encourage responsible budgeting practices.

By imposing this restriction on funds, the bill seeks to ensure that the Office of National Drug Control Policy operates within its means and prioritizes its resources in a way that best serves the American people. This measure is part of ongoing efforts to streamline government spending and promote fiscal responsibility within the federal government. Overall, Bill 118 hr 2071 represents a targeted approach to managing the budget of the Office of National Drug Control Policy, with the goal of maximizing the impact of taxpayer dollars and promoting good governance practices within this important government agency.